The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated×4•Originally published 16 April 2026•Updated 17 April 2026•

1 min read

US Stocks See Widespread Price Target Adjustments After Q1 Earnings

Key Facts

1Piper Sandler raised Intercontinental Exchange (ICE) price target to $211, citing record-high volumes and open interest.

about 2 months ago

Version History

Version 4about 2 months ago

What changed: Updated the report to include ICE's new $195.71 price target, its strong Piotroski Score of 8, and recent short-term price decline data.

Version 3about 2 months ago

What changed: JPMorgan issued a significant downgrade and price target cut for Clorox (CLX).

Version 2about 2 months ago

What changed: The story was updated to include a 'Buy' upgrade for ICE based on record trading volumes and a valuation comparison against CME Group.

Version 1about 2 months ago

What changed: The story was updated to include price target revisions for Republic Services (RSG) by JPMorgan and Wells Fargo, along with new analyst insights regarding the environmental services sector's growth outlook.

Major financial institutions have accelerated price target adjustments for US equities, with Intercontinental Exchange (ICE) now projected to have a 21.33% growth potential and a target price of $195.71. The company's outlook is supported by a strong Piotroski Score of 8, indicating robust financial health, despite a recent 3.06% price dip that may offer a strategic entry point. Conversely, JPMorgan downgraded Clorox (CLX) to Underweight with a $99 target, while Wells Fargo raised its outlook for Republic Services (RSG) to $252. These updates join increased targets for steel producers Nucor and Steel Dynamics, contrasting with Baird's cautious stance on UnitedHealth. Collectively, these revisions illustrate a strategic re-positioning by institutional investors based on sector-specific performance and shifting valuation metrics.